Objective:

To explore the reasons behind the reluctance of cataract surgeons to adopt minimally invasive glaucoma surgery (MIGS), focusing on personal preferences, comfort levels, and the impact of emerging technologies.

Approach:

Key Findings:

• Nearly half of glaucoma patients undergoing cataract surgery do not receive concomitant glaucoma treatment.
• Some surgeons may avoid MIGS due to a lack of interest in treating glaucoma.
• Surgeons uncomfortable with gonioscopy are less likely to perform MIGS.
• New technologies are emerging that could make glaucoma treatment more accessible for hesitant surgeons, such as the SpyGlass platform and excimer laser trabeculostomy.

Interpretation:

Surgeon reluctance to adopt MIGS may stem from personal preferences, lack of comfort with specific techniques, or past complications. However, advancements in glaucoma treatment are creating more options for these surgeons, potentially addressing their concerns.

Limitations:

• The article does not provide quantitative data on surgeon demographics or specific reasons for avoidance.
• It does not address the potential impact of patient education on surgeon decision-making.

Conclusion:

While some surgeons may choose to avoid MIGS, ongoing advancements in glaucoma treatment are likely to benefit both surgeons and patients.

Sources:

• Glaucoma Physician
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.